These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6311774)

  • 1. "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.
    Abbruzzese G; Gandolfo C; Loeb C
    Ital J Neurol Sci; 1983 Jun; 4(2):169-72. PubMed ID: 6311774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
    Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
    Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous methylprednisolone for multiple sclerosis in relapse.
    Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steroid therapy for multiple sclerosis].
    Oishi C; Sakuta M
    Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.
    Milanese C; La Mantia L; Salmaggi A; Campi A; Eoli M; Scaioli V; Nespolo A; Corridori F
    Eur Neurol; 1989; 29(1):10-4. PubMed ID: 2540005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
    Tremlett HL; Luscombe DK; Wiles CM
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids and multiple sclerosis.
    Miller DH
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):290. PubMed ID: 9728938
    [No Abstract]   [Full Text] [Related]  

  • 8. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
    Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Syndulko K; Holevoet-Howson MI; Lerner CD; Frane MV; Pettler-Jennings P
    Neurology; 1989 Aug; 39(8):1018-26. PubMed ID: 2668784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylprednisolone in multiple sclerosis: a comparative dose study.
    Bindoff L; Lyons PR; Newman PK; Saunders M
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1108-9. PubMed ID: 3063777
    [No Abstract]   [Full Text] [Related]  

  • 10. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1989; 23(3):188-92. PubMed ID: 2561379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corticoids and multiple sclerosis].
    Defer G; Cesaro P; Degos JD
    Ann Med Interne (Paris); 1994 Jun; 145 Suppl 2():37-41. PubMed ID: 8074340
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
    Uttner I; Müller S; Zinser C; Maier M; Süssmuth S; Claus A; Ostermann B; Elitok E; Ecker D; Brettschneider J; Gold R; Tumani H
    Neurology; 2005 Jun; 64(11):1971-3. PubMed ID: 15955958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1988; 22(5):399-403. PubMed ID: 2854886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
    Frequin ST; Lamers KJ; Borm GF; Barkhof F; Jongen PJ; Hommes OR
    Acta Neurol Scand; 1993 Aug; 88(2):80-6. PubMed ID: 8213063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
    Rinne UK
    Ann Med Intern Fenn; 1968; 57(4):167-72. PubMed ID: 4307479
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
    Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
    Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
    Blustein H; Wasserman RR; Halperin L; Garvin JS
    Med Times; 1969 Dec; 97(12):137-41. PubMed ID: 4312534
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
    Alam SM; Kyriakides T; Lawden M; Newman PK
    J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1219-20. PubMed ID: 8229035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
    Lyons PR; Newman PK; Saunders M
    J Neurol Neurosurg Psychiatry; 1988 Feb; 51(2):285-7. PubMed ID: 3346696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.